With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.12150-46-8,1,1-Bis(diphenylphosphino)ferrocene,as a common compound, the synthetic route is as follows.
General procedure: The stoichiometricamounts of [Cu(CH3CN)4](PF6)/Au(THT)Cl, K{S(O)COR} R = CH(CH3)2, CH2CH(CH3)2 and PPh3/dppf/PMe3 were taken in 100 mLround bottom flask containing 30 mL of acetone. The reaction mixturewas stirred at room temperature for 1 h under nitrogen atmosphere.The resultant solution was filtered and was evaporated todryness under vacuum to obtain a white solid. The residue was dissolvedin DCM and washed with water (3 20 mL). Finally theCH2Cl2 was evaporated to dryness under vacuum to yield complexesas fine white powders. The stoichiometry and the amountsof reagents used in each case are given below
12150-46-8, The synthetic route of 12150-46-8 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Cyue, Jhih-Yu; Kishore, Pilli V.V.N.; Liao, Jian-Hong; Lin, Yan-Ru; Liu; Inorganica Chimica Acta; vol. 462; (2017); p. 97 – 105;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate